1 University of North Carolina School of Medicine, Chapel Hill, North Carolina.
2 Memorial Sloan Kettering Cancer Center and Weill-Cornell Medical College, New York, New York.
Ann Am Thorac Soc. 2018 Dec;15(12):1451-1458. doi: 10.1513/AnnalsATS.201806-420OC.
Chronically critically ill patients are often dependent on family members for surrogate decision-making, and these surrogates are at high risk for emotional distress. We hypothesized that patient- and surrogate-specific risk factors for surrogate post-traumatic stress disorder (PTSD) symptoms can be identified early in the course of chronic critical illness.
To identify risk factors for PTSD symptoms in surrogate decision-makers of chronically critically ill patients.
We performed a secondary analysis of the database from a multicenter randomized trial of a communication intervention for chronic critical illness patients and surrogates. Variables preselected for plausible mechanism for increasing PTSD symptoms and identifiable by Day 10 of mechanical ventilation were included in the analysis for association with surrogate PTSD symptoms at 90 days, as measured by the Impact of Events Score-Revised (IES-R). Patient factors included demographics, insurance status, baseline functional status, chronic comorbidities, illness severity, and presence of advance directive. Surrogate variables included demographics, education level and employment, religion, relationship to patient, and Hospital Anxiety and Depression Scale score measured at enrollment. Multivariable linear regression models were then constructed for 26 potential risk factors, including biologically or mechanistically plausible confounders for each, with IES-R score as the outcome. All models were adjusted for multiple respondents, using a mixed model, considering the patients as a random factor.
Our analysis included 306 surrogates for 224 patients. A total of 49% of patients were female, and mean age was 59 years (95% confidence interval [CI], 56.4-60.7). A total of 71% of surrogates were female, and mean age was 51 years (95% CI, 49.3-52.4). After examining each potential risk factor in a separate multivariable model, only Day-10 surrogate Hospital Anxiety and Depression Scale score (β coefficient = 1.02; 95% CI, 0.73-1.30) and patient unresponsiveness (β coefficient = 8.39; 95% CI, 0.83-15.95) were associated with higher IES-R scores.
Among surrogate decision-makers for chronically critically ill patients, high anxiety and depression scores and patient unresponsiveness on or near Day 10 of mechanical ventilation are risk factors for PTSD symptoms at 90 days.
慢性危重症患者通常依赖家庭成员作为代理人进行决策,这些代理人面临着情绪困扰的高风险。我们假设,可以在慢性危重症患者病程早期识别出与代理人创伤后应激障碍(PTSD)症状相关的患者和代理人特定的危险因素。
确定慢性危重症患者代理人 PTSD 症状的危险因素。
我们对一项多中心、随机临床试验的数据库进行了二次分析,该试验针对慢性危重症患者及其代理人进行了沟通干预。纳入了与机械通气第 10 天的潜在机制有关的且可识别的变量,以分析这些变量与 90 天时代理人 PTSD 症状(采用修订后的事件影响量表(IES-R)测量)之间的关联。患者因素包括人口统计学特征、保险状况、基线功能状态、慢性合并症、疾病严重程度和预先指定的治疗方案。代理人变量包括人口统计学特征、教育水平和就业、宗教信仰、与患者的关系,以及在入组时测量的医院焦虑和抑郁量表评分。然后,我们使用混合模型构建了 26 个潜在危险因素的多变量线性回归模型,包括每个因素的生物学或机制上合理的混杂因素,以 IES-R 评分为因变量。所有模型均调整了多个应答者,将患者作为随机因素。
我们的分析包括了 224 名患者的 306 名代理人。共有 49%的患者为女性,平均年龄为 59 岁(95%置信区间[CI],56.4-60.7)。共有 71%的代理人为女性,平均年龄为 51 岁(95% CI,49.3-52.4)。在分别对每个潜在风险因素进行多变量模型分析后,仅第 10 天的代理医院焦虑和抑郁量表评分(β系数=1.02;95%CI,0.73-1.30)和患者无反应性(β系数=8.39;95%CI,0.83-15.95)与更高的 IES-R 评分相关。
在慢性危重症患者的代理人中,机械通气第 10 天或接近第 10 天的高焦虑和抑郁评分以及患者无反应性是 90 天时 PTSD 症状的危险因素。